Respiratory Syncytial Virus Infection
📧 Sign up to get email alerts when something new happens for Respiratory Syncytial Virus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: RSV Antibiotic Drivers And Resource-use
A completed clinical trial evaluating factors driving antibiotic use and resource utilization in Respiratory Syncytial Virus infections, con…
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization [Phase 3]
Phase 3 trial assessing the safety and efficacy of an RSV F protein vaccine administered to pregnant individuals to protect newborns from re…
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: A Study of AK0529 in Adults Patients Hospitalized With RSV Infection [Phase 2]
A Phase 2 clinical trial evaluating AK0529 in adults hospitalized with respiratory syncytial virus infection has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-11Clinical Trial Update: Study of a Single Intramuscular Dose of Nirsevimab in the Prevention of Hospitalizations Due to Respiratory Syncytial Virus (RSV) Infection in Healthy Term and Preterm Infants During the First Year of Life [Phase 3]
This Phase 3 trial evaluated a single intramuscular dose of nirsevimab to prevent hospitalizations due to respiratory syncytial virus in hea…
-
CLINICAL_TRIALS trial_result · 2025-04-01Clinical Trial Update: A Study on Safety and Immune Response of Investigational RSV OA Vaccine in Combination With Herpes Zoster Vaccine in Healthy Adults [Phase 3]
A Phase 3 study evaluating the safety and immune response of an investigational RSV OA vaccine in combination with a herpes zoster vaccine i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-28Clinical Trial Update: Transplacental Transmission of RSV (TTRSV)
The Tulane University-sponsored trial NCT05443607 investigates transplacental transmission of RSV (TTRSV). It covers conditions including SA…
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: Phase 2 Study of the RSV/Flu-01E Vaccine Against Respiratory Syncytial Virus Infection in Older Adults [Phase 2]
Phase 2 study of the RSV/Flu-01E vaccine in older adults has completed, sponsored by the Research Institute of Influenza in Russia.
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: Clinical Performance Evaluation of the NeuMoDx™ FluA/FluB/RSV/Severe Acute Respiratory Syndrome-CoV-2 Assay
Clinical performance evaluation of the NeuMoDx FluA/FluB/RSV/Severe Acute Respiratory Syndrome-CoV-2 assay completed, assessing detection of…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: A Study to Learn About the Safety and Immune Activity of RSVpreF in Children 2 to <18 Years of Age [Phase 1]
Phase 1 trial assessing safety and immune response of Pfizer's RSVpreF vaccine in children aged 2 to under 18; study completed with results …
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: Emission Patterns of Respiratory Syncytial Virus
Sponsored by Wake Forest University Health Sciences, the trial investigated emission patterns of the Respiratory Syncytial Virus (RSV). The …
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: A Study to Learn How the Study Medicine Called Sisunatovir is Tolerated and Acts in the Bodies of Chinese Healthy Adults. [Phase 1]
Pfizer conducted a Phase 1 study in healthy Chinese adults to evaluate tolerability, safety, and pharmacokinetics of sisunatovir; the trial …
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Safety and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV ΔNS2/Δ1313/I1314L, RSV 6120/ΔNS2/1030s, RSV 276 or Placebo, Delivered as Nose Drops to RSV-Seronegative Children 6 to 24 Months of Age [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the safety and immunogenicity of three recombinant live-attenuated RSV vaccines in RSV-seronegative chil…
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Evaluation of a Single Use Point of Care Device for the Diagnosis of Respiratory Pathogens
A study evaluating a single-use point-of-care diagnostic device for detecting multiple respiratory pathogens was terminated, with results po…
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy. [Phase 3]
Pfizer's RSVpreF Phase 3 trial evaluating efficacy and safety in infants born to women vaccinated during pregnancy has completed and posted …
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: Inpatient Challenge Study of rRSV A/Maryland/001/11, a Human Respiratory Syncytial Virus Challenge Strain, Administered to Healthy Adult Volunteers [Phase 1]
A Phase 1 inpatient RSV challenge trial in healthy adult volunteers using the rRSV A/Maryland/001/11 strain, with status noted as completed.
-
CLINICAL_TRIALS trial_result · 2025-02-04Clinical Trial Update: Efficacy and Safety of Clesrovimab (MK-1654) in Infants (MK-1654-004) [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating the efficacy and safety of the monoclonal antibody Clesrovimab (MK-1654) for respiratory syncyti…
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: Moderna Vaccine mRNA-1345 Observational Respiratory Syncytial Virus (RSV) Study
An observational study of Moderna's RSV vaccine candidate mRNA-1345 has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Efficacy of LiveSpo Navax in Supportive Treatment of Pneumonia in Children With RSV and Bacterial Co-infections [NA]
Clinical trial update on the efficacy of LiveSpo Navax as supportive treatment for pneumonia in children with RSV and bacterial co-infection…
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: The Effect of Sevoflurane on Airway Hyperreactivity During the Perioperative Period.
A clinical trial evaluated whether sevoflurane influences airway hyperreactivity during the perioperative period in children with RSV infect…
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Universal Anti-Viral Vaccine for Healthy Elderly Adults [Phase 1, Phase 2]
Phase 1/2 trial of a universal antiviral vaccine for healthy elderly adults has completed, evaluating safety across multiple viral infection…
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Mucosal Immunity: Influence on Infectious Viral Load: a Prospective Observational Study
A completed prospective observational study examining how mucosal immunity influences infectious viral load in SARS-CoV-2, influenza, and RS…
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: A Study to Learn About Two or More Vaccines That Are Put Together as One Shot Against Infectious Lung Illnesses, Including COVID-19 and Respiratory Syncytial Virus (RSV). [Phase 2]
Pfizer completed a Phase 2 trial evaluating a single-shot combination vaccine for COVID-19 and Respiratory Syncytial Virus (RSV); results ha…
-
CLINICAL_TRIALS trial_result · 2024-12-06Clinical Trial Update: Cell Mediated Immunity Against RSV and Influenza in a Human Experimental Challenge [NA]
This completed Imperial College London clinical study assessed cell-mediated immune responses to respiratory syncytial virus infection and i…
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: A Study to Examine Respiratory Combination Vaccines Against Respiratory Syncytial Virus (RSV) and Flu in Older Adults [Phase 1]
Pfizer completed a Phase 1 study of a respiratory combination vaccine targeting respiratory syncytial virus and influenza in healthy older a…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: MVA-BN-RSV Vaccine Trial [Phase 3]
Phase 3 trial of Bavarian Nordic's MVA-BN-RSV vaccine was terminated, with results posted on 2024-10-31.